March 2026 in “Journal of Sustainable Veterinary and Allied Sciences” In this case report, a 5-year-old female German shepherd diagnosed with canine babesiosis and ehrlichiosis fully recovered after receiving parenteral treatment for these infections and topical therapy for dermatitis at the University of Ilorin's Veterinary Teaching Hospital.
November 2025 in “International Journal of Bio-resource and Stress Management” This review discusses MRSA in dogs and its public health impact, highlighting interspecies transmission and the need for improved infection control and biosecurity measures, but reports no new experimental results.
October 2025 in “Diseases” The researchers suggest that inflammation could be a key mechanism in the development of long COVID, potentially causing symptoms that emerge months after the acute phase of the disease resolves.
October 2025 in “Brazilian Journal of Veterinary Research and Animal Science” The researchers reported a case of a neotropical porcupine co-infected with Brazilian porcupine poxvirus and Toxoplasma gondii, suggesting the need for further investigation into the impact of this interaction.
February 2025 in “International Journal of Research in Medical Sciences” This study found that patients with COVID-19 reinfection exhibited a higher prevalence of certain post-COVID complications, such as pain and weakness, compared to those with a single infection, and identified factors like gender and smoking habits as significantly associated with these complications.
January 2025 in “International Journal of Trichology” This retrospective study observed that telogen effluvium, a type of diffuse hair loss, frequently occurs in females aged 18–30 following SARS-CoV-2 infection, often accompanied by nutritional deficiencies, suggesting an association between COVID-19 and micronutrient deficiency, with acute cases being most common but chronic cases possible.
This study highlights the complexity of diagnosing scalp fungal infections, emphasizing how clinical evaluation, trichoscopy, and cultural samples are essential in distinguishing tinea capitis from similar conditions like piedra, seborrheic dermatitis, and psoriasis, due to overlapping symptoms like scaling and hair changes.
August 2024 in “Journal of Dermatology for Physician Assistants” In this review, potential causes of COVID-19 and immunization-induced hair loss are explored, highlighting the need for early treatment and further research to clarify whether stress, viral infection, treatment medications, or nutritional deficiencies are responsible.
February 2024 in “Indian Dermatology Online Journal” In this study, researchers at a tertiary care center reported a significant correlation between severe COVID-19 cases and the presence of androgenic alopecia, suggesting that androgen receptor expression may influence COVID-19 severity.
December 2023 in “FUDMA Journal of Sciences” In this study, researchers analyzed Vachellia nilotica and Senegalia ataxacantha from Katsina state, Nigeria, identifying various bioactive compounds in their shoots and suggesting their potential as raw materials for pharmaceutical antifungal therapies.
September 2023 in “Irish Journal of Medical Science (1971 -)” In this study, 61.4% of females infected with COVID-19 reported hair problems, such as telogen effluvium and increased gray hair, with most cases starting or worsening post-infection as confirmed by trichoscopy.
June 2023 in “Journal of Paediatrics and Child Health” This case report describes a child with tinea capitis who experienced complete lesion remission and hair regrowth after early diagnosis and treatment with antifungal medications, highlighting the importance of timely management to prevent complications like scarring and permanent hair loss.
March 2023 in “Медицинский совет” This review discusses various types of hair loss associated with COVID-19 and vaccinations, highlighting acute telogen hair loss as the most common form, but reports no new clinical results.
January 2023 in “Journal of Cosmetic Dermatology” This case series reports on three school-aged children developing alopecia areata shortly after COVID-19 infection, suggesting a potential association between the virus and this autoimmune hair loss condition.
December 2022 in “Journal of Education, Health and Sport” This review compiles existing knowledge on the mechanisms and diagnosis of various types of hair loss following COVID-19, including telogen effluvium and alopecia areata, and emphasizes the need to educate patients on these conditions.
December 2022 in “Journal of Education, Health and Sport” This review suggests that combining treatments such as oral supplements, topical minoxidil, and high-platelet plasma may be effective for addressing telogen effluvium after COVID-19 infection, which affects about 30% of patients.
August 2022 in “Journal of Pakistan Association of Dermatologists” This review summarizes findings on hair loss caused by COVID-19, noting that Telogen Effluvium frequently occurs in female patients 63 days post-infection, often in those with mild to moderate cases and certain comorbidities.
April 2022 in “Journal of biotechnology and strategic health research” This article presents a case of telogen effluvium, a condition causing hair loss, occurring three months after a COVID-19 infection.
March 2022 in “Brazilian Journal of Health Review” This study suggests that COVID-19 infection can lead to telogen effluvium, typically occurring 3-6 months post-infection, potentially linked to the virus's inflammatory and anticoagulation effects.
January 2022 in “Turkiye Klinikleri Journal of Dermatology” This study found that COVID-19 patients with skin symptoms had a shorter hospital stay than those without, suggesting these signs may indicate a different disease course.
June 2021 in “Aesthetic Cosmetology and Medicine” This review discusses excessive hair loss as a common symptom of COVID-19 infection, affecting both men and women regardless of age or other health conditions, but reports no new results.
April 2019 in “Journal of Investigative Dermatology” In this report, the potential connection between Merkel cell carcinoma and Curvularia lunata infection in an elderly patient is discussed, highlighting the need for precise diagnostic methods and suggesting that surgery combined with the antifungal voriconazole may be a viable treatment option.
December 2004 in “Microbial Ecology in Health and Disease” This study found that Pityriasis amiantacea was associated with Staphylococcus aureus infection, especially in young women of Bedouin origin, and responded well to antibiotic and topical treatments.
8 citations
,
January 2022 in “Infectious diseases News Opinions Training” This review discusses gene polymorphisms in COVID-19 patients but reports no new clinical findings.
2 citations
,
December 2021 in “World journal of dentistry” In this study, Cocos nucifera (coconut) oil's antimicrobial properties showed effectiveness against Candida albicans and Streptococcus in an in vitro biofilm model, and its lauric acid content may reduce plaque adhesion and support oral health.
June 2023 in “SPIRE - Sciences Po Institutional REpository” This study suggests that extracellular vesicles from prostate cancer cells could aid in identifying tumor heterogeneity and serve as biomarkers, while also playing a role in SARS-CoV-2 infection in nasopharyngeal mucus.
513 citations
,
February 2022 in “Advanced Science” This study demonstrated that incorporating PDA@Ag nanoparticles into a cationic guar gum hydrogel significantly enhanced photothermal conversion efficiency, achieving superior antibacterial efficacy both in vitro and in vivo, advancing the potential of PDA as a photothermal antibacterial agent.
133 citations
,
May 2016 in “Cell Host & Microbe” In this study, human dermal fibroblasts were identified as natural host cells that support productive Merkel cell polyomavirus infection, and the MEK antagonist trametinib was introduced as an effective inhibitor to control the virus.
95 citations
,
August 2022 in “JAMA Network Open” This study documented an increased health care burden due to post-COVID conditions in the 6 months following the acute phase of infection, providing vital evidence for resource planning.
87 citations
,
February 2019 in “Tissue Engineering Part B Reviews” This review discusses the antibacterial properties of platelet-rich plasma (PRP) and summarizes existing preclinical and clinical research on its use for preventing and treating wound and bone infections, but presents no novel data.